Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/32500432/ below:

The impact of COVID-19 pandemic in the colorectal cancer prevention

Affiliations

• ¹ Gastroenterology Unit, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy. giovanna.del.vecchio.blanco@uniroma2.it.
• ² Gastroenterology Unit, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy.

• PMID: 32500432
• PMCID: PMC7271141
• DOI: 10.1007/s00384-020-03635-6

Item in Clipboard

Giovanna Del Vecchio Blanco et al. Int J Colorectal Dis. 2020 Oct.

• ¹ Gastroenterology Unit, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy. giovanna.del.vecchio.blanco@uniroma2.it.
• ² Gastroenterology Unit, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy.

• PMID: 32500432
• PMCID: PMC7271141
• DOI: 10.1007/s00384-020-03635-6

Item in Clipboard

Background: The coronavirus disease 2019 (COVID-19) has led to a policy of severe restrictions in almost all countries strongly involved by the pandemic. National Health System is among activities suffering from the COVID-19 and the lockdown.

Aim: To evaluate the impact of COVID-19 in colorectal cancer (CRC) prevention.

Methods: We report the change in the hospital organization to meet the growing healthcare needs determined by COVID-19. The limitations of CRC prevention secondary to COVID-19 and their effects on the healthcare are analyzed considering the features of the CRC screening programs in the average-risk population and endoscopic surveillance in patients with inflammatory bowel diseases (IBD).

Results: The interruption of CRC prevention may lead to a delayed diagnosis of CRC, possibly in a more advanced stage. The economic burden and the impact on workload for gastroenterologists, surgeons, and oncologists will be greater as long as the CRC prevention remains suspended. To respond to the increased demand for colonoscopy once COVID-19 will be under control, we should optimize the resources. It will be necessary to stratify the CRC risk and reach an order of priority. It should be implemented the number of health workers, equipment, and spaces dedicated to performing colonoscopy for screening purpose and in subjects with alarm symptoms in the shortest time. To this aim, the funds earmarked for healthcare should be increased.

Conclusion: The economic impact will be dramatic, but COVID-19 is the demonstration that healthcare has to be the primary goal of humans.

Keywords: COVID-19; Colonoscopy; Colorectal cancer; Colorectal cancer screening; Fecal occult blood test.

PubMed Disclaimer

• Screening and Surveillance Colonoscopy and COVID-19: Avoiding More Casualties.

  Gupta S, Lieberman D. Gupta S, et al. Gastroenterology. 2020 Oct;159(4):1205-1208. doi: 10.1053/j.gastro.2020.06.091. Epub 2020 Jul 16. Gastroenterology. 2020. PMID: 32682766 Free PMC article. No abstract available.

• Impact of COVID-19 on colorectal cancer disparities and the way forward.

  Balzora S, Issaka RB, Anyane-Yeboa A, Gray DM 2nd, May FP. Balzora S, et al. Gastrointest Endosc. 2020 Oct;92(4):946-950. doi: 10.1016/j.gie.2020.06.042. Epub 2020 Jun 20. Gastrointest Endosc. 2020. PMID: 32574570 Free PMC article.

• Evaluation of endoscopy requests in the resumption of activity during the SARS-CoV-2 pandemic: denial of nonindicated requests and prioritization of accepted requests.

  Díez Redondo P, Núñez Rodríguez MªH, Fuentes Valenzuela E, Nájera Muñoz R, Perez-Miranda M. Díez Redondo P, et al. Rev Esp Enferm Dig. 2020 Oct;112(10):748-755. doi: 10.17235/reed.2020.7375/2020. Rev Esp Enferm Dig. 2020. PMID: 32954775

• Impact of the COVID-19 Pandemic on Colorectal Cancer Screening: a Systematic Review.

  Mazidimoradi A, Tiznobaik A, Salehiniya H. Mazidimoradi A, et al. J Gastrointest Cancer. 2022 Sep;53(3):730-744. doi: 10.1007/s12029-021-00679-x. Epub 2021 Aug 18. J Gastrointest Cancer. 2022. PMID: 34406626 Free PMC article. Review.

• ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancer.

  Vecchione L, Stintzing S, Pentheroudakis G, Douillard JY, Lordick F. Vecchione L, et al. ESMO Open. 2020 May;5(Suppl 3):e000826. doi: 10.1136/esmoopen-2020-000826. ESMO Open. 2020. PMID: 32457036 Free PMC article. Review.

• Cancer Screening in the Coronavirus Pandemic Era: Adjusting to a New Situation.

  Basu P, Alhomoud S, Taghavi K, Carvalho AL, Lucas E, Baussano I. Basu P, et al. JCO Glob Oncol. 2021 Mar;7:416-424. doi: 10.1200/GO.21.00033. JCO Glob Oncol. 2021. PMID: 33784177 Free PMC article.

• Gastrointestinal cancers, ACE-2/TMPRSS2 expression and susceptibility to COVID-19.

  Shafiee S, Cegolon L, Khafaei M, Gholami N, Zhao S, Khalesi N, Moosavian H, Fathi S, Izadi M, Ghadian A, Javanbakht M, Javanbakht A, Akhavan-Sigari R. Shafiee S, et al. Cancer Cell Int. 2021 Aug 16;21(1):431. doi: 10.1186/s12935-021-02129-x. Cancer Cell Int. 2021. PMID: 34399734 Free PMC article. Review.

• Cardiovascular tissue banking activity during SARS-CoV-2 pandemic: evolution of national protocols and Lombardy experience.

  Mastroiacovo G, Guarino A, Pirola S, Gennari M, Capriuoli F, Micheli B, Bonomi A, Piccolo G, Dainese L, Polvani G. Mastroiacovo G, et al. Cell Tissue Bank. 2021 Dec;22(4):675-683. doi: 10.1007/s10561-021-09959-z. Epub 2021 Sep 14. Cell Tissue Bank. 2021. PMID: 34523044 Free PMC article.

• Impact of COVID-19 on cancer diagnosis and management in Slovenia - preliminary results.

  Zadnik V, Mihor A, Tomsic S, Zagar T, Bric N, Lokar K, Oblak I. Zadnik V, et al. Radiol Oncol. 2020 Jul 29;54(3):329-334. doi: 10.2478/raon-2020-0048. Radiol Oncol. 2020. PMID: 32726291 Free PMC article.

• Impact of the COVID-19 pandemic and related control measures on cancer diagnosis in Catalonia: a time-series analysis of primary care electronic health records covering about five million people.

  Coma E, Guiriguet C, Mora N, Marzo-Castillejo M, Benítez M, Méndez-Boo L, Fina F, Fàbregas M, Mercadé A, Medina M. Coma E, et al. BMJ Open. 2021 May 18;11(5):e047567. doi: 10.1136/bmjopen-2020-047567. BMJ Open. 2021. PMID: 34006554 Free PMC article.

1. 1. Zorzi M, Senore C, Turrin A, Mantellini P, Visioli CB, Naldoni C, Sassoli De’ Bianchi P, Fedato C, Anghinoni E, Zappa M, Hassan C, Italian colorectal cancer screening survey group Appropriateness of endoscopic surveillance recommendations in organised colorectal cancer screening programmes based on the faecal immunochemical test. Gut. 2016;65:1822–1828. doi: 10.1136/gutjnl-2015-310139. - DOI - PubMed
2. 1. Gini A, Jansen EEL, Zielonke N, Meester RGS, Senore C, Anttila A, Segnan N, Mlakar DN, de Koning HJ, Lansdorp-Vogelaar I, EU-TOPIA consortium Impact of colorectal cancer screening on cancer-specific mortality in Europe: a systematic review. Eur J Cancer. 2020;127:224–235. doi: 10.1016/j.ejca.2019.12.014. - DOI - PubMed
3. 1. Moss S, Ancelle-Park R, Brenner H. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition. Evaluation and interpretation of screening outcomes. Endoscopy. 2012;44:SE49–SE64. doi: 10.1055/s-0031-1291525. - DOI - PubMed
4. 1. Paterson WG, Depew WT, Pare P, Petrunia D, Switzer C, Veldhuyzen van Zanten SJ, et al. Canadian consensus on medically acceptable wait times for digestive health care. Can J Gastroenterol. 2006;20:411–423. doi: 10.1155/2006/343686. - DOI - PMC - PubMed
5. 1. Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, Jr, Garcia FAR, et al. Screening for colorectal cancer: US preventive services task force recommendation statement. JAMA. 2016;315:2564–2575. doi: 10.1001/jama.2016.5989. - DOI - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3